Brazilian stingless bee propolis and geopropolis: promising sources of biologically active compounds

Brazilian stingless bee propolis and geopropolis: promising sources of biologically active compounds

Publication: Rev Bras Farmacogn
Software: ADMET Predictor®

Stingless bee products such as honey, pollen, propolis, and geopropolis have been used for centuries in traditional medicine for the treatment of several illnesses.

Exploration of sexual dimorphism and inter-individual variability in multivariate parameter spaces for a pharmacokinetic compartment model

Exploration of sexual dimorphism and inter-individual variability in multivariate parameter spaces for a pharmacokinetic compartment model

Software: GastroPlus®

Pharmacokinetic models are particularly useful to study the underlying and complex physiological mechanisms contributing to clinical differences across patient subgroups or special populations.

PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data

PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data

Publication: Regul Toxicol Pharmacol

Physiologically-based toxicokinetic (PBTK) models are mathematical representations of chemical absorption, distribution, metabolism and excretion (ADME) in animals.

Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability

Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability

Publication: Biopharm Drug Dispos
Software: ADMET Predictor®

The present study evaluated the potential of five generally recognized as safe (GRAS) or dietary compounds (α‐mangostin, chrysin, ginger extract, pterostilbene and silybin) to inhibit oxidative (CYP) and conjugative (UGT) metabolism...

Pediatric Physiologically Based Pharmacokinetic Model Development: Current Status and Challenges

Pediatric Physiologically Based Pharmacokinetic Model Development: Current Status and Challenges

Authors: Lin W, Yan JE, Heimbach T, He H
Publication: Curr Pharmacol Rep

This article provides a brief overview of the development of pediatric physiologically based pharmacokinetic (PPBPK) models, the challenges of uncertain systems information, and finally...

Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6

Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6

Authors: Uba AI, Yelekçi K
Publication: Comput Biol Chem
Software: ADMET Predictor®

Histone deacetylase (HDAC) 6 plays a role in oncogenic transformation and cancer metastasis via tubulin deacetylation, making it a critical target for anticancer drug design.

Evaluation of blood-brain barrier penetration and examination of binding to human serum albumin of 7-O-arylpiperazinylcoumarins as potential antipsychotic agents

Evaluation of blood-brain barrier penetration and examination of binding to human serum albumin of 7-O-arylpiperazinylcoumarins as potential antipsychotic agents

Publication: Bioorg Chem
Software: ADMET Predictor®

The delivery of drugs to the brain is complicated by the multiple factors including low blood–brain barrier (BBB) passive permeability, active BBB efflux systems, and plasma protein binding.

8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages

8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages

Publication: Bioorg Med Chem
Software: ADMET Predictor®

Extracellular adenosine 5′-triphosphate (ATP) triggers the P2X7 receptor (P2X7R) ionic channel to stimulate the release of the interleukin-IL-1β cytokine into macrophages.

Physiologically based absorption modeling to predict bioequivalence of controlled release and immediate release oral products

Physiologically based absorption modeling to predict bioequivalence of controlled release and immediate release oral products

Publication: Eur J Pharm Biopharm
Software: GastroPlus®

Physiologically based absorption modeling was conducted to predict bioequivalence (BE) for immediate release (IR) and controlled release (CR) formulations.

Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents

Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents

Publication: Cells
Software: ADMET Predictor®

Specific modifications of colchicine followed by synthesis of its analogues have been tested in vitro with the objective of lowering colchicine toxicity.

Tools and resources for metabolomics research community: A 2017–2018 update

Tools and resources for metabolomics research community: A 2017–2018 update

Authors: Misra BB, Mohapatra S
Publication: Electrophoresis
Software: ADMET Predictor®

The scale at which MS‐ and NMR‐based platforms generate metabolomics datasets for both research, core, and clinical facilities to address challenges in the various sciences—ranging from biomedical to agricultural—is underappreciated.

A Rapid Method to Estimate Hepatocyte Loss Due to Drug‐Induced Liver Injury

A Rapid Method to Estimate Hepatocyte Loss Due to Drug‐Induced Liver Injury

Publication: Clin Pharmacol Ther
Software: DILIsym®

It is not currently possible to rapidly estimate the extent of hepatocyte loss during drug‐induced liver injury (DILI). We used a proprietary mechanistic model (DILIsym) to estimate percentage hepatocyte loss due...

Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001

Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001

Publication: J Chromatogr B
Software: ADMET Predictor®

This study investigated pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats. Stability study and metabolism study of ACT001 are conducted.

In vitro and in vivo investigation of metabolic fate of riociguat by HPLC-Q-TOF/MS/MS and in silico evaluation of the metabolites by ADMET Predictor™

In vitro and in vivo investigation of metabolic fate of riociguat by HPLC-Q-TOF/MS/MS and in silico evaluation of the metabolites by ADMET Predictor™

Publication: J Pharm Biomed Anal
Software: ADMET Predictor®

Riociguat, a guanyl cyclase inhibitor, is one of its kind drug regimen approved for management of pulmonary arterial hypertension and chronic thromboembolism pulmonary hypertension.